Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Seattle Genetics

Seattle Genetics, Inc. is a biotechnology company developing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Our strategy is focused on advancing our portfolio of product candidates in diseases with unmet medical need and significant market potential. We have more than 150 employees and are located in a high-technology campus in Bothell, Washington, a suburb of Seattle.


Contact Details:
22215 26th Avenue S. E.
Bothell
Washington
98021
United States of America
Tel:(425) 527-4000
Fax:(425) 527-4001
Email:contact@seagen.com
WWW:

www.seattlegenetics.com/




Loading...

Recent Publications by Seattle Genetics:

Potent antibody drug conjugates for cancer therapy.
Significant progress has been made in the past few years in the area of...
1st October, 2009
Seattle Genetics, Inc., 21823 30th Dr. SE, Bothell, WA 98021, United Curr Opin Chem Biol. 2009 Jun;13(3):235-44. Epub 2009 May 4.
DOI Direct Link
Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis.
Rheumatoid arthritis (RA) is characterized by inflammation and cellular...
24th September, 2009
Department of Preclinical Therapeutics, Seattle Genetics, Bothell, J Immunol. 2009 Sep 15;183(6):3770-7. Epub 2009 Aug 26.
DOI Direct Link
The pharmacologic basis for antibody-auristatin conjugate activity.
Antibody-drug conjugates (ADCs) made with auristatin antimitotic agents...
22nd September, 2009
Seattle Genetics, Inc., 21823 30th Drive SE, Bothell, WA 98021, USA. J Pharmacol Exp Ther. 2009 Sep;330(3):932-8. Epub 2009 Jun 4.
DOI Direct Link
Targeting CD30/CD30L in Oncology and Autoimmune and Inflammatory Diseases.
The transmembrane receptor CD30 (TNFRSF8) and its ligand CD30L (CD153,...
18th September, 2009
Department of Preclinical Therapeutics, Seattle Genetics, Inc, 21823 30th Adv Exp Med Biol. 2009;647:174-85.
DOI Direct Link
Targeting CD70 for Human Therapeutic Use.
Expression of CD70, a member of the tumor necrosis factor superfamily, is...
18th September, 2009
Department of Preclinical Therapeutics, Seattle Genetics, Inc., Bothell, Adv Exp Med Biol. 2009;647:108-19.
DOI Direct Link

View more Seattle Genetics research publications.

Press Releases on Seattle Genetics:

BioPortfolio Logo
Reportlinker Adds Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight 5th November, 2009 Reportlinker
NEW YORK, Nov. 5 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
Oncothyreon announces appointment of Douglas E. Williams, Ph.D., to board of directors 5th October, 2009 Oncothyreon Inc.
SEATTLE, Oct. 5 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX: ONY) today announced the appointment of Douglas E. Williams, Ph.D., Chief Executive Officer of ZymoGenetics, Inc. (Nasdaq
New Report Just Published: World Multiple Myeloma Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Multiple Myeloma Therapeutics Market http://www.reportlinker.com/p0119496/World
New Report Just Published: World Prostate Cancer Therapeutics Market Report 7th July, 2009 Reportlinker
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue. World Prostate Cancer Therapeutics Market http://www.reportlinker.com/p0119471/World

BioNews Results for Seattle Genetics:

Seattle Genetics (SGEN) Bearish Technical Alert - Trend Down 14.6...
Zibb:  Nov 11 2009 12:50AM Matching: seattle genetics
Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money
Xconomy:  Nov 11 2009 2:57PM Matching: seattle genetics
Alder Rides Momentum of $1B Deal, Aims to Give Amgen and Abbott a Run for Their Money
Xconomy:  Nov 11 2009 7:40AM Matching: seattle genetics
Seattle Genetics (SGEN) Bearish Technical Alert - Trend Down 14.6%
TradingMarkets:  Nov 10 2009 11:42PM Matching: seattle genetics
San DiegoEURs PaxVax Developing Oral Tablet Vaccine, Looks to Raise More Cash With Support of Seattles Ignit
Xconomy:  Nov 9 2009 7:08PM Matching: seattle genetics
Promote your company here: BioNewsCast - Press Release Distribution

View more Seattle Genetics news.

Seattle Genetics Clinical Trials:

A Safety Study in Patients With Chronic Lymphocytic Leukemia

Seattle Genetics Patents:

US Patent No.Title
7553816 p-amidobenzylethers in drug delivery agents
6843989 Methods for the treatment and prevention of cancer using anti-CD40 antibodies
6884869 Pentapeptide compounds and uses related thereto
6946129 Recombinant anti-CD40 antibody and uses thereof
7090843 Recombinant anti-CD30 antibodies and uses thereof

View more Seattle Genetics patents.

Seattle Genetics (SGEN) Financial information Links from Barchart

SGEN Quote from from Barchart.com
SGEN Chart from from Barchart.com
SGEN Profile from from Barchart.com
SGEN Opinion from from Barchart.com

View more Seattle Genetics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 468 times since April 2007, the link to the organisation's website has been followed 80 times

Recent Search Terms used to find this page: logo for seattle genetics | .

Search for more companies in Bothell

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Seattle Genetics

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.